Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantation

Michael R. Bishop, Seth M. Steinberg, Ronald E. Gress, Nancy M. Hardy, Donna Marchigiani, Claude Sportes, Robert Dean, Steven Z. Pavletic, Juan Gea-Banacloche, Kathleen Castro, Fran Hakim, Michael Krumlauf, Elizabeth J. Read, Charles Carter, Susan F. Leitman, Daniel H. Fowler

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Mixed chimaerism and graft rejection are higher after reduced-intensity allogeneic stem cell transplantation (RIST) with T-cell depleted (TCD) allografts. As host immune status before RIST affects engraftment, we hypothesized that targeted depletion of host lymphocytes prior to RIST would abrogate graft rejection and promote donor chimaerism. Lymphocyte-depleting chemotherapy was administered at conventional doses to subjects prior to RIST with the intent of decreasing CD4+ counts to <0.05 × 10 9 cells/1. Subjects (n = 18) then received reduced-intensity conditioning followed by ex vivo TCD human leucocyte antigen-matched sibling allografts. All evaluable patients (n = 17) were engrafted; there were no late graft failures. At day +28 post-RIST, 12 patients showed complete donor chimaerism. Mixed chimaerism in the remaining five patients was associated with higher numbers of circulating host CD3+ cells (P = 00032) after lymphocyte-depleting chemotherapy and was preferentially observed in T lymphoid rather than myeloid cells. Full donor chimaerism was achieved in all patients after planned donor lymphocyte infusions. These data reflect the importance of host immune status prior to RIST and suggest that targeted host lymphocyte depletion facilitates the engraftment of TCD allografts. Targeted lymphocyte depletion may permit an individualized approach to conditioning based on host immune status prior to RIST.

Original languageEnglish (US)
Pages (from-to)837-843
Number of pages7
JournalBritish Journal of Haematology
Volume126
Issue number6
DOIs
StatePublished - Sep 1 2004

Fingerprint

Lymphocyte Depletion
Stem Cell Transplantation
T-Lymphocytes
Tissue Donors
Allografts
Graft Rejection
Lymphocytes
Drug Therapy
Myeloid Cells
CD4 Lymphocyte Count
HLA Antigens
Siblings
Transplants

Keywords

  • Allogeneic
  • Graft rejection
  • Reduced-intensity
  • T-cell depletion

ASJC Scopus subject areas

  • Hematology

Cite this

Bishop, M. R., Steinberg, S. M., Gress, R. E., Hardy, N. M., Marchigiani, D., Sportes, C., ... Fowler, D. H. (2004). Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantation. British Journal of Haematology, 126(6), 837-843. https://doi.org/10.1111/j.1365-2141.2004.05133.x

Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantation. / Bishop, Michael R.; Steinberg, Seth M.; Gress, Ronald E.; Hardy, Nancy M.; Marchigiani, Donna; Sportes, Claude; Dean, Robert; Pavletic, Steven Z.; Gea-Banacloche, Juan; Castro, Kathleen; Hakim, Fran; Krumlauf, Michael; Read, Elizabeth J.; Carter, Charles; Leitman, Susan F.; Fowler, Daniel H.

In: British Journal of Haematology, Vol. 126, No. 6, 01.09.2004, p. 837-843.

Research output: Contribution to journalArticle

Bishop, MR, Steinberg, SM, Gress, RE, Hardy, NM, Marchigiani, D, Sportes, C, Dean, R, Pavletic, SZ, Gea-Banacloche, J, Castro, K, Hakim, F, Krumlauf, M, Read, EJ, Carter, C, Leitman, SF & Fowler, DH 2004, 'Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantation', British Journal of Haematology, vol. 126, no. 6, pp. 837-843. https://doi.org/10.1111/j.1365-2141.2004.05133.x
Bishop, Michael R. ; Steinberg, Seth M. ; Gress, Ronald E. ; Hardy, Nancy M. ; Marchigiani, Donna ; Sportes, Claude ; Dean, Robert ; Pavletic, Steven Z. ; Gea-Banacloche, Juan ; Castro, Kathleen ; Hakim, Fran ; Krumlauf, Michael ; Read, Elizabeth J. ; Carter, Charles ; Leitman, Susan F. ; Fowler, Daniel H. / Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantation. In: British Journal of Haematology. 2004 ; Vol. 126, No. 6. pp. 837-843.
@article{1c0a5b47d98f48ecaace25b4b7b01bea,
title = "Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantation",
abstract = "Mixed chimaerism and graft rejection are higher after reduced-intensity allogeneic stem cell transplantation (RIST) with T-cell depleted (TCD) allografts. As host immune status before RIST affects engraftment, we hypothesized that targeted depletion of host lymphocytes prior to RIST would abrogate graft rejection and promote donor chimaerism. Lymphocyte-depleting chemotherapy was administered at conventional doses to subjects prior to RIST with the intent of decreasing CD4+ counts to <0.05 × 10 9 cells/1. Subjects (n = 18) then received reduced-intensity conditioning followed by ex vivo TCD human leucocyte antigen-matched sibling allografts. All evaluable patients (n = 17) were engrafted; there were no late graft failures. At day +28 post-RIST, 12 patients showed complete donor chimaerism. Mixed chimaerism in the remaining five patients was associated with higher numbers of circulating host CD3+ cells (P = 00032) after lymphocyte-depleting chemotherapy and was preferentially observed in T lymphoid rather than myeloid cells. Full donor chimaerism was achieved in all patients after planned donor lymphocyte infusions. These data reflect the importance of host immune status prior to RIST and suggest that targeted host lymphocyte depletion facilitates the engraftment of TCD allografts. Targeted lymphocyte depletion may permit an individualized approach to conditioning based on host immune status prior to RIST.",
keywords = "Allogeneic, Graft rejection, Reduced-intensity, T-cell depletion",
author = "Bishop, {Michael R.} and Steinberg, {Seth M.} and Gress, {Ronald E.} and Hardy, {Nancy M.} and Donna Marchigiani and Claude Sportes and Robert Dean and Pavletic, {Steven Z.} and Juan Gea-Banacloche and Kathleen Castro and Fran Hakim and Michael Krumlauf and Read, {Elizabeth J.} and Charles Carter and Leitman, {Susan F.} and Fowler, {Daniel H.}",
year = "2004",
month = "9",
day = "1",
doi = "10.1111/j.1365-2141.2004.05133.x",
language = "English (US)",
volume = "126",
pages = "837--843",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantation

AU - Bishop, Michael R.

AU - Steinberg, Seth M.

AU - Gress, Ronald E.

AU - Hardy, Nancy M.

AU - Marchigiani, Donna

AU - Sportes, Claude

AU - Dean, Robert

AU - Pavletic, Steven Z.

AU - Gea-Banacloche, Juan

AU - Castro, Kathleen

AU - Hakim, Fran

AU - Krumlauf, Michael

AU - Read, Elizabeth J.

AU - Carter, Charles

AU - Leitman, Susan F.

AU - Fowler, Daniel H.

PY - 2004/9/1

Y1 - 2004/9/1

N2 - Mixed chimaerism and graft rejection are higher after reduced-intensity allogeneic stem cell transplantation (RIST) with T-cell depleted (TCD) allografts. As host immune status before RIST affects engraftment, we hypothesized that targeted depletion of host lymphocytes prior to RIST would abrogate graft rejection and promote donor chimaerism. Lymphocyte-depleting chemotherapy was administered at conventional doses to subjects prior to RIST with the intent of decreasing CD4+ counts to <0.05 × 10 9 cells/1. Subjects (n = 18) then received reduced-intensity conditioning followed by ex vivo TCD human leucocyte antigen-matched sibling allografts. All evaluable patients (n = 17) were engrafted; there were no late graft failures. At day +28 post-RIST, 12 patients showed complete donor chimaerism. Mixed chimaerism in the remaining five patients was associated with higher numbers of circulating host CD3+ cells (P = 00032) after lymphocyte-depleting chemotherapy and was preferentially observed in T lymphoid rather than myeloid cells. Full donor chimaerism was achieved in all patients after planned donor lymphocyte infusions. These data reflect the importance of host immune status prior to RIST and suggest that targeted host lymphocyte depletion facilitates the engraftment of TCD allografts. Targeted lymphocyte depletion may permit an individualized approach to conditioning based on host immune status prior to RIST.

AB - Mixed chimaerism and graft rejection are higher after reduced-intensity allogeneic stem cell transplantation (RIST) with T-cell depleted (TCD) allografts. As host immune status before RIST affects engraftment, we hypothesized that targeted depletion of host lymphocytes prior to RIST would abrogate graft rejection and promote donor chimaerism. Lymphocyte-depleting chemotherapy was administered at conventional doses to subjects prior to RIST with the intent of decreasing CD4+ counts to <0.05 × 10 9 cells/1. Subjects (n = 18) then received reduced-intensity conditioning followed by ex vivo TCD human leucocyte antigen-matched sibling allografts. All evaluable patients (n = 17) were engrafted; there were no late graft failures. At day +28 post-RIST, 12 patients showed complete donor chimaerism. Mixed chimaerism in the remaining five patients was associated with higher numbers of circulating host CD3+ cells (P = 00032) after lymphocyte-depleting chemotherapy and was preferentially observed in T lymphoid rather than myeloid cells. Full donor chimaerism was achieved in all patients after planned donor lymphocyte infusions. These data reflect the importance of host immune status prior to RIST and suggest that targeted host lymphocyte depletion facilitates the engraftment of TCD allografts. Targeted lymphocyte depletion may permit an individualized approach to conditioning based on host immune status prior to RIST.

KW - Allogeneic

KW - Graft rejection

KW - Reduced-intensity

KW - T-cell depletion

UR - http://www.scopus.com/inward/record.url?scp=4644349775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644349775&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2004.05133.x

DO - 10.1111/j.1365-2141.2004.05133.x

M3 - Article

C2 - 15352988

AN - SCOPUS:4644349775

VL - 126

SP - 837

EP - 843

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 6

ER -